Development of HPV vaccines for HPV-associated head and neck squamous cell carcinoma.
about
Pathophysiological basis of human papillomavirus in penile cancer: Key to prevention and delivery of more effective therapiesTargeted Therapy in Locally Advanced and Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma (LA-R/M HNSCC)Recent Progress in Therapeutic Treatments and Screening Strategies for the Prevention and Treatment of HPV-Associated Head and Neck CancerHuman papilloma virus in squamous carcinoma of the head and neck: a study of cases in south east Scotland.A conserved E7-derived cytotoxic T lymphocyte epitope expressed on human papillomavirus 16-transformed HLA-A2+ epithelial cancers.Differences in history of sexual behavior between patients with oropharyngeal squamous cell carcinoma and patients with squamous cell carcinoma at other head and neck sitesT cell-tumor interaction directs the development of immunotherapies in head and neck cancer.Molecular biology of squamous cell carcinoma of the head and neckEpigallocatechin-3-gallate enhances CD8+ T cell-mediated antitumor immunity induced by DNA vaccination.Does pretreatment seropositivity to human papillomavirus have prognostic significance for head and neck cancers?Induction of CD4-independent E7-specific CD8+ memory response by heat shock fusion proteinPreventive and Therapeutic Vaccines against Human Papillomaviruses Associated Cervical CancersMolecular pathology of head and neck cancer: implications for diagnosis, prognosis, and treatmentOncogenic impact of human papilloma virus in head and neck cancer.The clinical implications of antitumor immunity in head and neck cancer.An HPV-E6/E7 immunotherapy plus PD-1 checkpoint inhibition results in tumor regression and reduction in PD-L1 expression.Immunotherapy of head and neck cancer: current and future considerations.Identification and characterization of enhancer agonist human cytotoxic T-cell epitopes of the human papillomavirus type 16 (HPV16) E6/E7.Immunity to squamous carcinoma in mice immunized with dendritic cells transfected with genomic DNA from squamous carcinoma cells.A non-pathogenic live vector as an efficient delivery system in vaccine design for the prevention of HPV16 E7-overexpressing cancers.Therapeutic human papillomavirus vaccines: current clinical trials and future directions
P2860
Q26744446-87A9CD6D-FD54-45DB-9264-EDE8D9A711CAQ26765429-E8F81849-6D96-40A6-B042-1B1917B5F85AQ26782255-CD4D2407-7CD5-460F-B07A-7F4D2FA19575Q33280921-F71156F2-3819-4F16-9C56-EA72C5EDBE45Q34121681-15DB8C68-6364-48E4-A0FB-3429151C8B60Q34367405-52929920-B32C-44EF-A1E4-F6160CB4F58CQ34475726-4B96C98C-3323-4A35-B2B4-D2C0F5A618A1Q34518716-E2110B37-A02A-4815-A094-38D9EF099057Q35234948-FF9CFF8B-6CD5-4CFC-B312-4A2EA0513D1BQ35647100-A88FEE59-6AC4-4181-8DFC-104596831F67Q36097148-1501F922-6DB9-408C-8E23-1C61BD51417DQ36652548-4B24DC6E-A6E8-4868-A51A-DBDC8D8608E6Q36988805-9A015CE9-5C04-4016-B460-B4295178361AQ37762309-FA3A0837-2336-4FA6-8B24-50922AC38064Q37970005-BE4724EE-F10F-4FCD-B4F0-1D895FA8B0B0Q38838178-D333A5A2-0422-44DF-A483-95D3AEFF4AB8Q39955461-DA9303CF-831D-414F-BA7D-8D25CEC99559Q40252793-2E7C4FB3-467D-4C74-8F2A-57A08E5AA6D0Q40423103-94595E3C-BB0D-4DAB-B411-6F151FA5B42FQ45888118-A5A8B324-5326-4578-93CE-8855E0927329Q56937332-FC00E3AB-C2B3-4BEE-9FE9-39EC948ABD86
P2860
Development of HPV vaccines for HPV-associated head and neck squamous cell carcinoma.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
2003年论文
@zh
2003年论文
@zh-cn
name
Development of HPV vaccines for HPV-associated head and neck squamous cell carcinoma.
@ast
Development of HPV vaccines for HPV-associated head and neck squamous cell carcinoma.
@en
type
label
Development of HPV vaccines for HPV-associated head and neck squamous cell carcinoma.
@ast
Development of HPV vaccines for HPV-associated head and neck squamous cell carcinoma.
@en
prefLabel
Development of HPV vaccines for HPV-associated head and neck squamous cell carcinoma.
@ast
Development of HPV vaccines for HPV-associated head and neck squamous cell carcinoma.
@en
P2093
P2860
P1476
Development of HPV vaccines for HPV-associated head and neck squamous cell carcinoma.
@en
P2093
Kalpana Devaraj
Maura L Gillison
P2860
P304
P356
10.1177/154411130301400505
P407
P577
2003-01-01T00:00:00Z